Redefining MENA's Pharmaceutical Landscape: The Shift from Import Reliance to Local Production
The pharmaceutical industry across the Middle East and North Africa is experiencing a dramatic pivot. For years, nations in this region depended almost entirely on overseas suppliers, with some countries importing as much as 90% of their medications. However, pandemic aftershocks, fragile global logistics, and bold national strategies are now compelling governments to rethink their approach fundamentally.
Across the region, from Egypt's sprawling manufacturing facilities to the UAE's next-generation biotech corridors, a critical question has emerged: how can nations guarantee access to advanced treatments while simultaneously nurturing homegrown pharmaceutical capabilities? This conversation has moved well beyond economics — it now touches health sovereignty, crisis preparedness, and strategic independence. These very discussions are shaping agendas at every leading Pharma Conference Dubai ga